A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Polen Capital Management LLC holds 7,768,779 shares of NVO stock, worth $1.02 Billion. This represents 2.3% of its overall portfolio holdings.

Number of Shares
7,768,779
Previous 7,958,444 2.38%
Holding current value
$1.02 Billion
Previous $823 Million 21.16%
% of portfolio
2.3%
Previous 1.98%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $19.4 Million - $25.8 Million
-189,665 Reduced 2.38%
7,768,779 $998 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $4.58 Million - $5.5 Million
52,189 Added 0.66%
7,958,444 $823 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $719 Million - $1.58 Billion
7,906,255 New
7,906,255 $719 Million
Q1 2020

May 11, 2020

SELL
$49.46 - $64.78 $5.88 Million - $7.7 Million
-118,809 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$49.86 - $58.26 $2.48 Million - $2.89 Million
49,660 Added 71.82%
118,809 $6.88 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $466,177 - $523,934
9,806 Added 16.52%
69,149 $3.58 Million
Q2 2019

Aug 12, 2019

BUY
$46.79 - $52.47 $626,424 - $702,468
13,388 Added 29.13%
59,343 $3.03 Million
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $659,934 - $749,188
14,235 Added 44.88%
45,955 $2.4 Million
Q4 2018

Feb 12, 2019

BUY
$41.54 - $47.25 $247,993 - $282,082
5,970 Added 23.18%
31,720 $1.46 Million
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $57,561 - $63,076
1,231 Added 5.02%
25,750 $1.21 Million
Q2 2018

Aug 09, 2018

BUY
$44.29 - $50.42 $92,388 - $105,176
2,086 Added 9.3%
24,519 $1.13 Million
Q1 2018

May 11, 2018

BUY
$48.49 - $58.14 $180,091 - $215,931
3,714 Added 19.84%
22,433 $1.11 Million
Q4 2017

Feb 09, 2018

BUY
$47.53 - $53.73 $56,750 - $64,153
1,194 Added 6.81%
18,719 $1.01 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $721,153 - $862,580
17,525
17,525 $844,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $298B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track Polen Capital's Portfolio

Track Polen Capital Portfolio

Follow Polen Capital (Polen Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.